Management Team

• Dr. Wang Hao - Executive Director, Chief Executive Officer and Chief Scientist

  Dr. Wang Hao ("Dr. Wang") was appointed as an Executive Director and Chief Scientist of the Company in July 2018, and was appointed as the Chief Executive Officer of the Company in October 2020. He is primarily responsible for overseeing the operation and management of our Group and has over 24 years of experience in the medical and pharmaceutical technology industry.

  Dr. Wang obtained a Ph.D. in medicine in June 1997 from the Second Military Medical University (currently known as the People's Liberation Army Navy Medical University).

  Dr. Wang was awarded twice with the National Award for Science and Technology Progress in December 2011 and December 2007, respectively, the Shanghai Oriental Scholar Professorship in June 2008, and the Shanghai Award for Science and Technology Progress in December 2003.

• Mr. Li Yunfeng - Executive Director, Vice President and Joint Company Secretary

  Mr. Li Yunfeng ("Mr. Li") was appointed as an Executive Director of the Company in July 2018, and has served as the Joint Company Secretary since May 2019. Mr. Li was appointed as the Vice President of the Company in July 2024. He is primarily responsible for overseeing the Group's management of business development, investment and legal work. Mr. Li has over 20 years of experience in the biotechnology industry.

• Mr. Tao Jing - Executive Director and Vice President

  Mr. Tao Jing ("Mr. Tao") joined the Group in February 2015 and was appointed as the vice president of the Company and general manager of Taizhou Mabtech Pharmaceutical Co., Ltd., an indirect wholly-owned subsidiary of the company, in August 2018. Mr. Tao was appointed as the executive director of the Company in Octorber 2020 and was elected as a member of the sixth session of the Standing Committee of Taizhou Gaogang District People's Congress in January 2022. He is primarily responsible for overseeing production of drugs of the Group. Mr. Tao also obtained an advanced certificate in biochemistry from Shanghai Municipal Human Resources and Social Security Bureau in November 2013.

• Dr. Hou Sheng - Executive Director and Vice President

  Dr. Hou Sheng ("Dr. Hou") was appointed as an executive director of the Company in November 2023, and was appointed as a vice president of the Company in December 2023. He is mainly responsible for overseeing the Group's medical, drug registration and clinical studies. Dr. Hou has over 20 years of experience in oncology and biology fields. Dr. Hou received a Ph.D. in medicine from the Second Military Medical University (currently known as People's Liberation Army Navy Medical University) in June 2005.

  Dr. Hou received second prize in State Technological Invention Award in 2007, first prize in Shanghai Science and Technology Award two times in 2006 and 2011 respectively, and second prize in Shanghai Technology Invention Award.

• Dr. Qian Weizhu - Executive Director and Vice President

  Dr. Qian Weizhu ("Dr. Qian") joined the Group in February 2015 and served as an executive director and Chief Executive Officer of the Company from August 2018 to October 2020. Dr. Qian was appointed as a non-executive director of the Company in November 2023 and was re-designated as an executive director and vice president of the Company in July 2024. Dr. Qian has more than 25 years of experience in oncology and biology fields and was awarded a doctorate degree in oncology from Second Military Medical University (currently known as People's Liberation Army Navy Medical University) in June 2011.

Joint Company Secretaries

• Mr. Li Yunfeng - Executive Director, Vice President and Joint Company Secretary

  Mr. Li Yunfeng ("Mr. Li") was appointed as an Executive Director of the Company in July 2018, and has served as the Joint Company Secretary since May 2019. Mr. Li was appointed as the Vice President of the Company in July 2024. He is primarily responsible for overseeing the Group's management of business development, investment and legal work. Mr. Li has over 20 years of experience in the biotechnology industry.

• Mr. Tsang Ho Yin - Joint Company Secretary

  Mr. Tsang Ho Yin ("Mr. Tsang") was appointed as a Joint Company Secretary of the Company. Mr. Tsang obtained a bachelor degree in laws and commerce (accounting) from University of Melbourne, Australia in August 2008 and then obtained a master degree in laws from the same university in August 2010. Mr. Tsang then obtained the Postgraduate Certificate in Laws from the City University of Hong Kong in July 2011. Mr. Tsang was admitted as a solicitor in Australia and Hong Kong in May 2012 and December 2013, respectively. Mr. Tsang passed the Guangdong-Hong Kong-Macao Greater Bay Area Legal Professional Examination in 2022. Mr. Tsang is currently a partner of Stevenson, Wong & Co and Allbright Law (Hong Kong) Office LLP, specialising in corporate finance and commercial law.